Riquent FDA Approval Status

FDA Approved: No
Brand name: Riquent
Generic name: abetimus sodium
Company: La Jolla Pharmaceutical Company
Treatment for: Lupus

Development timeline for Riquent

Date	Article
Mar 14, 2005	La Jolla Pharmaceutical Announces Outcome of Recent FDA Discussions
Oct 14, 2004	La Jolla Pharmaceutical Company Receives Letter From FDA About Riquent
Feb 17, 2004	La Jolla Pharmaceutical’s New Drug Application for Lupus Drug Candidate Riquent Accepted for Review by FDA

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.